Friday, 2 July 2010

Clarification re media comment on Sativex

Published on the MS Trust website 02 July 2010 - GW Pharma
In response to a story in a regional UK media outlet yesterday, GW wishes to make the following clarification:
The story covered a decision by certain Primary Care Trusts (PCT) in a region of the UK that they were not paying for Sativex prescriptions. GW wishes to clarify that this decision was made last year, prior to the approval of Sativex when Sativex was only available on a "named patient" basis. At that time, Sativex was not approved in the UK.  For more click here